home / stock / bicx / bicx news

BICX News and Press, BioCorRx Inc. From 04/10/20

Stock Information
Company Name: BioCorRx Inc.
Stock Symbol: BICX
Market: OTC
Website: biocorrx.com
Menu
BICX BICX Quote BICX Short BICX News BICX Articles BICX Message Board
Get BICX Alerts

News, Short Squeeze, Breakout and More Instantly...
BICX - BioCorRx Offers Free Access to the UnCraveRx(TM) Mobile Platform for Weight Loss Management During COVID-19 Pandemic

ANAHEIM, CA, April 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that it is offering free access to the UnCraveRxȒ...
BICX - BioCorRx Offers Free Access to the UnCraveRx Mobile Platform for Weight Loss Management During COVID-19 Pandemic

Anaheim, CA - ( NewMediaWire ) - April 10, 2020 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that it is offering free access to the UnCraveRx™ App for a limited...

BICX - BioCorRx Offers Free Access to the BioCorRx Recovery Program Mobile Platform for Medical Professionals During COVID-19 Pandemic

ANAHEIM, CA, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that it is offering substance use disorder (SUD) medic...

BICX - Covid-19-related announcements - healthcare

Kiniksa Pharmaceuticals (NASDAQ: KNSA ) announces "early evidence" of treatment response in COVID-19-related pneumonia and hyperinflammation with antibody mavrilimumab. Shares up  42%  premarket. More news on: Kiniksa Pharmaceuticals, Ltd., Vaccinex, Inc., BioCorRx Inc., Health...
BICX - BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic

ANAHEIM, CA, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update and reported on recent corporate deve...

BICX - BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder

ANAHEIM, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, has been awarded an additional $2.8 million. This is the second tranche ...

BICX - BioCorRx Provides 2019 Year-End Business Update

ANAHEIM, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a year-end business update for 2019 and reported on recen...
BICX - BioCorRx up 8% on encouraging data on opioid overdose candidate

Ultra-thinly traded nano cap BioCorRx ( OTCQB:BICX +7.7% ) is up, albeit on only 700 shares, in reaction to encouraging preclinical data on VDM-001, its candidate for the reversal of opioid overdose that it says is an alternative to naloxone. More news on: BioCorRx Inc., Aurobindo Phar...

BICX - BioCorRx's Subsidiary, BioCorRx Pharmaceuticals Provides Update on Potential Overdose Reversal Drug Candidate VDM-001

Early preclinical data suggests VDM-001 may prevent overdose from fentanyl ANAHEIM, CA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addictio...

BICX - BioCorRxs Subsidiary, BioCorRx Pharmaceuticals Provides Update on Potential Overdose Reversal Drug Candidate VDM-001

Early preclinical data suggests VDM-001 may prevent overdose from fentanyl Anaheim, CA - ( NewMediaWire ) - December 03, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and relat...
Previous 10 Next 10